Humira Kit
Product Images NDC 0074-0616

Product Visual Gallery

This gallery contains 79 technical images submitted to the FDA as part of the official labeling for Humira (NDC 0074-0616). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Abbvie Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Title: Fig1-acr20 (Humira 01)

A line graph comparing the percentage of ACR20 responders over time (in weeks) between a 40 mg every other week treatment group and a placebo group. The graph shows higher responder rates for the 40 mg group compared to placebo throughout the 48-week period.*

FDA Label Image

Title: Fig2-asas20-response (Humira 02)

A line graph comparing the percentage of ASAS 20 response over time (weeks) between Humira (N=208) and placebo (N=107). The graph shows Humira with a higher response percentage, peaking around 8-10 weeks, while placebo response remains significantly lower throughout the 24-week period.*

FDA Label Image

Title: Km-graph-fig3-study-uv-i (Humira 03)

A line graph comparing treatment failure rates over a 20-month period for treatments labeled as Humira and placebo. The x-axis represents time in months, and the y-axis represents treatment failure rate as a percentage.*

FDA Label Image

Title: Uveitis-km-fig3-part2 (Humira 04)

A line graph showing treatment failure rates over time in months. The graph compares three groups labeled Treatment, Placebo, and Humira, with the y-axis representing treatment failure rate percentages and the x-axis representing time in months.*

FDA Label Image

Title: Km-peds-uv (Humira 05)

A Kaplan-Meier plot showing the probability of failing treatment over time in weeks, comparing Humira and placebo groups. The solid line represents Humira, and the dashed line represents placebo, with the Humira group showing a lower probability of treatment failure across the time period.*

FDA Label Image

Title: Fig-a-pen-image (Humira 06)

An illustration of the Humira autoinjector pen highlighting its component parts, including a plum-colored cap (Cap #2), plum-colored activator button, window, white needle sleeve, and gray cap (Cap #1). The diagram labels each part to show the autoinjector's structure.*

FDA Label Image

Title: Fig-b-pen-with-window (Humira 07)

Illustration showing a hand holding a Humira injection pen, with a close-up inset highlighting the fill line indicator on the medication window of the pen.*

FDA Label Image

Title: Humira-fig-c-hand-with-pen-b (Humira 08)

An instructional illustration showing a hand holding a Humira prefilled injection pen by AbbVie Inc. The image focuses on the positioning and grip of the pen, highlighting its external features including a cap and a lock symbol on the device.*

FDA Label Image

Title: Injectable Areas (Humira 09)

An illustration showing recommended injectable areas for Humira on the human body. The diagram highlights three injection sites: the lower abdomen around the navel and the front of both thighs. The areas are shaded and labeled 'Injectable Areas.'*

FDA Label Image

Title: Humira-pen-fig-e-hand-hold-gray-cap-b (Humira 0a)

An instructional illustration showing a hand holding a Humira autoinjector pen, with the cap removed from the needle end, exposing a red safety guard. The image demonstrates correct positioning for use of the device, labeled with the brand name Humira by AbbVie Inc.*

FDA Label Image

Title: Humira-pen-fig-f-gray-cap-removal-b (Humira 0b)

Instructional illustration showing two hands removing a cap from a prefilled syringe. An arrow indicates the direction to pull the cap upwards. This image depicts part of the preparation process for Humira, a product by AbbVie Inc.*

FDA Label Image

Title: Humira-pen-fig-g-plum-cap-removal-b (Humira 0c)

Illustration showing a hand holding a Humira injection pen with the cap on top. The image appears to demonstrate how to correctly hold the pen for injection. The product Humira is labeled from AbbVie Inc.*

FDA Label Image

Title: Squeezed Skin (Humira 0d)

An instructional illustration showing a hand holding a device against a shoulder, possibly demonstrating the application or use of a medical or injection device on the shoulder area.*

FDA Label Image

Title: Ifu-40mg-0-8ml-figj-pen-angle (Humira 0e)

An instructional illustration showing hands holding a pen-like device at a 90-degree angle to the abdomen, indicating the proper angle for injection or application.*

FDA Label Image

Title: Pen Ten Second Injection (Humira 0f)

An instructional illustration showing a person holding a Humira injection pen against the thigh, preparing for injection. A stopwatch indicating 10 seconds suggests the recommended injection duration. The image includes a 'click' sound effect, indicating activation or completion of the injection.*

FDA Label Image

Title: Fig-l-yellow-indicator (Humira 10)

Illustration of a Humira prefilled pen showing the device with a red cap and a yellow indicator. An enlarged close-up highlights the yellow indicator that signals proper use or activation. The labeler is AbbVie Inc.*

FDA Label Image

Title: Pen White Needle Sleeve (Humira 11)

Illustration showing parts of a Humira prefilled syringe, specifically highlighting the white needle sleeve and the yellow window marker. The image includes arrows pointing to these components for identification purposes.*

FDA Label Image

Title: Ifu-pen-fign-sharp-cont (Humira 12)

An instructional illustration showing a hand discarding a used prefilled syringe of Humira into a sharps disposal container, indicating safe disposal of the injection device.*

FDA Label Image

Title: Fig-a-ifu-40mg-pen (Humira 13)

An instructional diagram of the Humira single-dose pen showing its components labeled: gray cap #1 covering the needle, white needle sleeve with a white arrow, inspection window, needle, plum activator button, and plum-colored cap #2. The image illustrates the pen's disassembled parts from cap to needle end.*

FDA Label Image

Title: Step1-pen-ifu-40mg (Humira 14)

An instructional illustration labeled 'STEP 1' depicting a hand holding a small black device or applicator near a set of objects including a syringe, a vial, and a cotton ball, likely indicating the initial preparation step for using the product Humira by AbbVie Inc.*

FDA Label Image

Title: Ifu-40mg-0-4ml-pen-step2 (Humira 15)

An instructional illustration labeled Step 2 depicting a sharps disposal container and a hand holding small objects above it, alongside a Humira prefilled syringe with a needle cap and two alcohol wipes, indicating proper disposal and preparation steps for the Humira injection.*

FDA Label Image

Title: Humira Mai Ifu Resize Step3 (Humira 16)

An instructional diagram labeled 'STEP 3' showing the recommended injectable areas for a subcutaneous injection. The illustration identifies the abdomen and front thigh regions as appropriate sites for injection, with arrows pointing to these areas on a simplified human figure.*

FDA Label Image

Title: Humira Mai Ifu Resize1 Step4 (Humira 17)

An instructional illustration labeled Step 4 showing a hand holding a pen-like device, likely an injection pen, with a close-up inset highlighting a specific feature near the top of the device. A downward-pointing arrow indicates the next action or step to follow.*

FDA Label Image

Title: Humira-mai-ifu-resize1-step5 (Humira 18)

An instructional diagram labeled Step 5 illustrating the removal sequence of two caps from a pen injector device. The image shows Cap #1 being removed first, followed by the removal of Cap #2, with arrows indicating the direction for each step.*

FDA Label Image

Title: Ifu-40mg-0-4ml-pen-step6 (Humira 19)

An instructional diagram showing Step 6 of an injection process for Humira by AbbVie Inc. It depicts a hand holding a syringe at a 90-degree angle for injection, with placement options indicated on the abdomen or thigh. The diagram includes a close-up illustration of the injection site on the thigh.*

FDA Label Image

Title: Humira Mai Ifu Resize1 Step7 (Humira 1a)

An instructional illustration labeled Step 7 showing a hand holding a Humira injectable pen against the skin. The image indicates to hold the pen in place for 10 seconds until a 'click' sound is heard, with a close-up inset of the pen's indicator window, which displays an orange line as part of the injection completion signal.*

FDA Label Image

Title: Humira Mai Ifu Resize1 Step8 (Humira 1b)

An instructional diagram labeled Step 8 showing a hand holding a device horizontally while the other hand pulls a component from the opposite end, indicated by a black arrow pointing right. This likely depicts part of the injection or medication preparation process for Humira by AbbVie Inc.*

FDA Label Image

Title: Ifu-40mg0-4ml-pen-step9 (Humira 1c)

An instructional illustration showing a hand placing a Humira prefilled syringe into a sharps disposal container, indicating proper disposal technique for the used injection device.*

FDA Label Image

Title: Humira Mai Ifu Resize1 Calendar (Humira 1d)

FDA Label Image

Title: Humira Mai Ifu Abbvie Logo (Humira 1e)

FDA Label Image

Title: Step1-80mg-ifu (Humira 1f)

An instructional illustration showing a hand removing or placing a rectangular object labeled as Step 1, suggesting the initial step in a process related to Humira, produced by AbbVie Inc.*

FDA Label Image

Title: 80mg-mai-ifu-step4 (Humira 20)

An instructional illustration showing Step 4 of using a Humira prefilled pen. The image depicts a hand holding the pen with a zoomed-in inset focusing on the pen's indicator window, highlighting the administration process.*

FDA Label Image

Title: Ifu-80mg-0-8ml-pen-step6 (Humira 21)

An instructional illustration showing Step 6 for Humira injection. It depicts a hand holding a syringe at a 90-degree angle to the abdomen or thigh, indicating the proper injection technique and angle for administering the medication.*

FDA Label Image

Title: 80mg-mai-ifu-step7-arrow (Humira 22)

An instructional illustration labeled Step 7 demonstrates holding a Humira pen and pressing it down, with a timer indicating 15 seconds. A close-up inset shows a window on the pen with a yellow indicator, and the word "click" signifies an audible cue during the step.*

FDA Label Image

Title: 80mg-mai-ifu-logo (Humira 23)

FDA Label Image

Title: Syringe Image (Humira 24)

An instructional diagram of a Humira prefilled syringe showing labeled parts: plunger rod, finger grip, and needle cover. The illustration highlights the components of the injection device used for subcutaneous administration.*

FDA Label Image

Title: Syringe Hand Holding (Humira 25)

An illustration showing a hand holding a syringe device with a pink plunger and needle guard, likely depicting an injection or administration step. The syringe is oriented vertically with the needle pointing down.*

FDA Label Image

Title: Fig-d-ifu-three-syringes (Humira 26)

Illustration showing three prefilled syringes for Humira by AbbVie Inc., labeled as 40 mg with 0.8 mL, 20 mg with 0.4 mL, and 10 mg with 0.2 mL of medication volume respectively.*

FDA Label Image

Title: Needle Cover Removal (Humira 27)

An instructional illustration showing two hands preparing a syringe. One hand holds the syringe barrel while the other removes the needle cap by pulling it straight off. The image is related to the preparation of Humira by AbbVie Inc.*

FDA Label Image

Title: Syringe Air Out (Humira 28)

An instructional illustration showing hands holding a syringe, with one hand securing the syringe barrel and the other hand pulling the plunger. The image appears to demonstrate the correct technique for preparing the syringe for injection. No specific product branding or labeling is visible in the image.*

FDA Label Image

Title: Syringe Hold Like Pencil (Humira 29)

An instructional illustration showing a hand holding a syringe with the needle pointing outward, demonstrating how to hold the device for injection preparation or administration.*

FDA Label Image

Title: Syringe Injection Angle (Humira 2a)

An instructional illustration showing a hand holding an injection pen at a 45-degree angle against the abdomen of another person, demonstrating the proper technique for subcutaneous injection. No specific product or dosage information is visible.*

FDA Label Image

Title: Syringe Injection Site Pressure (Humira 2b)

An instructional illustration showing a hand holding a small circular object, presumably a medical patch or device, being applied to the lower leg or ankle area. The image focuses on the application steps, highlighting the location on the body where the product should be placed.*

FDA Label Image

Title: Ifu-single-dose-pfs-figk-sharps (Humira 2c)

An instructional illustration showing a hand disposing of a used syringe with pink liquid into a sharps disposal container. The image indicates the correct placement of the syringe into the container opening with a downward arrow.*

FDA Label Image

Title: Fig-a-exploded-pfs (Humira 2d)

An instructional diagram labeled "HUMIRA Single-Dose Prefilled Syringe" showing parts of the syringe including the plunger, finger grip, and needle cover. The illustration outlines the syringe components for Humira, a product by AbbVie Inc.*

FDA Label Image

Title: Ifu-single-dpse-pfs-step2 (Humira 2e)

An instructional illustration labeled Step 2 showing a hand holding a syringe and applying it towards a sharps disposal container. It also depicts additional items related to injection preparation beside the container, indicating proper use and disposal steps.*

FDA Label Image

Title: Syringe-pms-step3 (Humira 2f)

An instructional diagram showing Step 3 for Humira injection, highlighting the injectable areas on the body. The image depicts the abdomen and thigh regions with marked areas for injection, emphasizing proper site selection for the subcutaneous administration of Humira by AbbVie Inc.*

FDA Label Image

Title: Step4-pfs-ifu (Humira 30)

An instructional illustration labeled "STEP 4" showing a hand holding a syringe-like device and another hand pulling back a protective cap or cover from the device.*

FDA Label Image

Title: Syringe-pms-step5 (Humira 31)

An instructional illustration labeled Step 5 shows a hand holding a syringe and another hand adjusting or holding the syringe cap or needle cover, indicating a step in the preparation or administration process of a medication.*

FDA Label Image

Title: Syringe-pms-step6 (Humira 32)

An instructional illustration labeled Step 6 showing a hand injecting a syringe into the skin of an arm. The image highlights the injection process with a close-up inset of the needle entering the skin.*

FDA Label Image

Title: New-step-7-syringes (Humira 33)

Instructional diagram labeled Step 7, demonstrating how to inject a medication subcutaneously into the abdomen or thigh. The image shows a hand holding a syringe and indicating the injection sites on the abdomen or thigh.*

FDA Label Image

Title: Step8-ifu-pfs (Humira 34)

Instructional illustration labeled Step 8 showing a person injecting a medication into the abdominal area using a handheld auto-injector device. This step is part of a sequence demonstrating the self-administration process for Humira (adalimumab).*

FDA Label Image

Title: Ifu-single-dose-pfs-step9 (Humira 35)

An instructional illustration showing a hand holding a device or pen above a square container or disposal box, labeled as 'STEP 9' indicating part of a step-by-step process.*

FDA Label Image

Title: Syringe-ifu-pms-abbvie-logo (Humira 36)

FDA Label Image

Ndc 0074-0124-03 Starter Pack For Crohn’s Disease,ulcerative Colitis, Or Hidradenitis Suppurativa3 Single-dose Prefilled Penshumira® Pen Adalimumab80 mg/0.8 mLfor Subcutaneous Use Only80mg/0.8 mL29 Gauge Needleeach Sterile Single-dose Prefilled Pen Contains:adalimumab..............80 mg Mannitol.................33.6 mg Polysorbate 80.........0.8 mg Water For Injection, Usp Sodium Hydroxide Added As Necessary To Adjust Ph. Contains No Preservatives. No U.s. Standard Of Potency. Attention Pharmacist: Each Patient Is Required To Receive The Enclosed Medication Guide.needle Cover For Syringe Is Not Made With Natural Rubber Latex. Carton Contains: • 3 Dose Trays (each Containing 1 Single-dose Prefilled Pen With 29 Gauge 1/2 Inch Length Fixed Needle)• 4 Alcohol Preps• 1 Package Insert• 1 Medication Guide• 1 Instructions For Usethe Entire Carton Is To Be Dispensed As A Unit. Do Not Accept If Seal Is Broken Or Missing.return To Pharmacy If Dose Tray Seal Is Broken Or Missing.humira.comrx Onlyabbvie (Humira 37)

Humira Pen packaging label from AbbVie Inc. The carton design includes dosage information for 80 mg per 0.8 mL, indicating a prefilled pen dosage form. The packaging features instructions and indications for use, including conditions such as Crohn's disease, ulcerative colitis, and rheumatoid arthritis, visible on the label panels.*

FDA Label Image

Ndc 0074-0124-04starter Pack Forpediatric Ulcerative Colitispatients ≥ 40 Kg80 mg/0.8 mL29 Gauge Needle4 Single-dose Prefilled Penshumira® Penadalimumab80 mg/0.8 mLfor Subcutaneous Use Onlyeach Sterile Single-dose Prefilled Pen Contains:adalimumab..............80 mg Mannitol.................33.6 mg Polysorbate 80.........0.8 mg Water For Injection, Usp Sodium Hydroxide Added As Necessary To Adjust Ph. Contains No Preservatives. No U.s. Standard Of Potency. Attention Pharmacist: Each Patient Is Required To Receive The Enclosed Medication Guide.needle Cover For Syringe Is Not Made With Natural Rubber Latex.carton Contains:• 4 Dose Trays (each Containing 1 Single-dose Prefilled Pen With 29 Gauge 1/2 Inch Length Fixed Needle)• 4 Alcohol Preps• 1 Package Insert• 1 Medication Guide• 1 Instructions For Usethe Entire Carton Is To Be Dispensed As A Unit. Do Not Accept If Seal Is Broken Or Missing.return To Pharmacy If Dose Tray Seal Is Broken Or Missing.humira.comrx Onlyabbvie (Humira 38)

Packaging label layout for Humira Pen by AbbVie Inc. The design features a predominantly light blue background with detailed instructions, dosage information, and branding elements. It includes dosage strength of 80 mg per 0.8 mL for pediatric ulcerative colitis patients, along with step-by-step usage instructions and barcode placement.*

FDA Label Image

Ndc 0074-0124-73 Not For Salestarter Pack For Crohn’s Disease,ulcerative Colitis, Or Hidradenitis Suppurativa3 Single-dose Prefilled Penshumira® Pen Adalimumab80 mg/0.8 mLfor Subcutaneous Use Only80 mg/0.8 mL29 Gauge Needleeach Sterile Single-dose Prefilled Pen Contains:adalimumab..............80 mg Mannitol.................33.6 mg Polysorbate 80.........0.8 mg Water For Injection, Usp Sodium Hydroxide Added As Necessary To Adjust Ph. Contains No Preservatives. No U.s. Standard Of Potency. Attention Physician: Each Patient Is Required To Receive The Enclosed Medication Guide.needle Cover For Syringe Is Not Made With Natural Rubber Latex.carton Contains:• 3 Dose Trays (each Containing 1 Single-dose Prefilled Pen With 29 Gauge 1/2 Inch Length Fixed Needle)• 4 Alcohol Preps• 1 Package Insert• 1 Medication Guide• 1 Instructions For Usethe Entire Carton Is To Be Dispensed As A Unit. Do Not Accept If Seal Is Broken Or Missing.return To Physician If Dose Tray Seal Is Broken Or Missing.humira.comrx Onlyabbvie (Humira 39)

The image shows a flat carton packaging template for Humira Pen by AbbVie Inc. The packaging includes labeling for 80 mg/0.8 mL adalimumab, indicating it is a starter pack for Crohn's disease, ulcerative colitis, and hidradenitis suppurativa. The template contains detailed product information, usage instructions, barcodes, and color-coded dose indicators on a light blue background.*

FDA Label Image

Ndc 0074-1539-03 Psoriasis/uveitisstarter Pack 3 Single-dose Prefilled Penshumira® Pen Adalimumabone 80 mg/0.8 mLtwo 40 mg/0.4 mLfor Subcutaneous Use Only80 mg/0.8 mL40 mg/0.4 mL29 Gauge Needleeach 80 mg/0.8 mL Sterile Single-dose Prefilled Pen Contains:adalimumab..............80 mg Mannitol.................33.6 mg Polysorbate 80..........0.8 mg Water For Injection, Usp Each 40 mg/0.4 mL Sterile Single-dose Prefilled Pen Contains:adalimumab..............40 mg Mannitol.................16.8 mg Polysorbate 80..........0.4 mg Water For Injection, Usp Contains No Preservatives. No U.s. Standard Of Potency. Attention Pharmacist: Each Patient Is Required To Receive The Enclosed Medication Guide.needle Cover For Syringe Is Not Made With Natural Rubber Latex.carton Contains:• 3 Dose Trays (each Containing 1 Single-dose Prefilled Pen With 29 Gauge 1/2 Inch Length Fixed Needle)• 4 Alcohol Preps• 1 Package Insert• 1 Medication Guide• 1 Instructions For Usethe Entire Carton Is To Be Dispensed As A Unit. Do Not Accept If Seal Is Broken Or Missing.store In Carton Until Time Of Administration.return To Pharmacy If Dose Tray Seal Is Broken Or Missing.humira.comrx Onlyabbvie (Humira 3a)

Packaging label for Humira Pen (adalimumab) by AbbVie Inc. This is a starter pack designed for psoriasis/uveitis treatment. The label indicates it contains a prefilled pen with dosages 80 mg/0.8 mL and 40 mg/0.4 mL. The design includes dosing instructions, safety information, barcodes, and illustrations related to injection.*

FDA Label Image

Ndc 0074-0817-02 2 Single-dose Prefilled Syringeshumira®adalimumab10 mg/0.1 mLfor Subcutaneous Use Only10 mg/0.1 mL29 Gauge Needleattention Pharmacist: Each Patient Is Required To Receive The Enclosed Medication Guide.needle Cover For Syringe Is Not Made With Natural Rubber Latex. The Entire Carton Is To Be Dispensed As A Unit.return To Pharmacy If Dose Tray Seal Is Broken Or Missing. This Carton Contains:• 2 Dose Trays Each Containing 1 Single-dose Prefilled Syringe With 29 Gauge 1/2 Inch Length Fixed Needle.• 2 Alcohol Preps• 1 Medication Guide• 1 Package Insert• Instructions For Usehumira.comrx Onlyabbvie (Humira 3b)

Packaging label for Humira 10 mg/0.1 mL single-dose prefilled syringe by AbbVie Inc. The label includes dosage strength, unit volume, and usage instructions for subcutaneous use. It features branding, barcode, lot and expiration details, and safety warnings on a mainly blue and white folded carton template.*

FDA Label Image

Ndc 0074-0616-02 2 Single-dose Prefilled Syringeshumira®adalimumab20 mg/0.2 mLfor Subcutaneous Use Only20 mg/0.2 mL29 Gauge Needleattention Pharmacist: Each Patient Is Required To Receive The Enclosed Medication Guide.needle Cover For Syringe Is Not Made With Natural Rubber Latex. The Entire Carton Is To Be Dispensed As A Unit.return To Pharmacy If Dose Tray Seal Is Broken Or Missing. This Carton Contains:• 2 Dose Trays (each Containing 1 Single-dose Prefilled Syringe With 29 Gauge 1/2 Inch Length Fixed Needle)• 2 Alcohol Preps• 1 Medication Guide• 1 Package Insert• 1 Instructions For Userx Onlyhumira.comabbvie (Humira 3c)

Packaging label for Humira 20 mg/0.2 mL prefilled syringes. The label shows the proprietary name Humira with the active ingredient adalimumab. The labeler is AbbVie Inc. The packaging includes multiple panels with dosage strength information, usage instructions, barcode, and lot number details. The design uses blue, white, and yellow colors with black and red text.*

FDA Label Image

Ndc 0074-3799-02 2 Single-dose Prefilled Syringeshumira®adalimumab 40 mg/0.8 mL Syringefor Subcutaneous Use Onlyattention Pharmacist: Each Patient Is Required To Receive The Enclosed Medication Guide.needle Cover For Syringe May Contain Dry Natural Rubber.the Entire Carton Is To Be Dispensed As A Unit. Return To Pharmacy If Dose Tray Seal Is Broken Or Missing. This Carton Contains:• 2 Dose Trays (each Containing 1 Single-dose Prefilled Syringe With 1/2 Inch Length Fixed Needle)• 2 Alcohol Preps• 1 Medication Guide• 1 Package Insert• 1 Instructions For Usewww.humira.comrx Onlyabbvie (Humira 3d)

Packaging label for Humira (adalimumab) provided by AbbVie Inc. The label is predominantly maroon with sections of gray and white text panels. It includes the product name Humira with adalimumab clearly displayed multiple times, as well as a 40 mg/0.8 mL prefilled syringe dosage indication. The label also contains barcode elements, lot number, and other regulatory information typical for a pharmaceutical carton.*

FDA Label Image

Humira-no-image-available (Humira 3e)

FDA Label Image

Ndc 0074-3799-71 Not For Sale2 Single-dose Prefilled Syringeshumira®adalimumab 40 mg/0.8 mL Syringefor Subcutaneous Use Onlyattention Physician: Each Patient Is Required To Receive The Enclosed Medication Guide.needle Cover For Syringe May Contain Dry Natural Rubber.the Entire Carton Is To Be Dispensed As A Unit. Return To Physician If Dose Tray Seal Is Broken Or Missing. This Carton Contains:• 2 Dose Trays (each Containing 1 Single-dose Prefilled Syringe With 1/2 Inch Length Fixed Needle)• 2 Alcohol Preps• 1 Medication Guide• 1 Package Insert• 1 Instructions For Usewww.humira.comrx Onlyabbvie (Humira 3f)

Packaging label for Humira 40 mg/0.8 mL prefilled syringe by AbbVie Inc. The label shows the proprietary name Humira with the active ingredient adalimumab, strength 40 mg/0.8 mL, and details for single-use prefilled syringes. The carton design includes barcodes and safety warnings, with primary colors of maroon and gray.*

FDA Label Image

Ndc 0074-9374-02 2 Single-dose Prefilled Syringeshumira®adalimumab 20 mg/0.4 mL Syringefor Subcutaneous Use Onlyattention Pharmacist: Each Patient Is Required To Receive The Enclosed Medication Guide.needle Cover For Syringe May Contain Dry Natural Rubber.the Entire Carton Is To Be Dispensed As A Unit. Return To Pharmacy If Dose Tray Seal Is Broken Or Missing. This Carton Contains:• 2 Dose Trays (each Containing 1 Single-dose Prefilled Syringe With 1/2 Inch Length Fixed Needle)• 2 Alcohol Preps• 1 Medication Guide• 1 Package Insert• 1 Instructions For Usewww.humira.comrx Onlyabbvie (Humira 40)

Packaging label for Humira (adalimumab), a prescription medication. The carton design includes the product name Humira and the active ingredient adalimumab prominently displayed in magenta and black text. The label also features the labeler name AbbVie Inc., barcodes, dosage form indication for subcutaneous use, and includes sections for product information and warnings. The color scheme includes shades of grey, white, and magenta accents.*

FDA Label Image

Ndc 0074-9374-71 Not For Sale2 Single-dose Prefilled Syringeshumira®adalimumab 20 mg/0.4 mL Syringefor Subcutaneous Use Onlyattention Physician: Each Patient Is Required To Receive The Enclosed Medication Guide.needle Cover For Syringe May Contain Dry Natural Rubber.the Entire Carton Is To Be Dispensed As A Unit. Return To Physician If Dose Tray Seal Is Broken Or Missing. This Carton Contains:• 2 Dose Trays (each Containing 1 Single-dose Prefilled Syringe With 1/2 Inch Length Fixed Needle)• 2 Alcohol Preps• 1 Medication Guide• 1 Package Insert• 1 Instructions For Usewww.humira.comrx Onlyabbvie (Humira 41)

Packaging label for Humira Pen, containing adalimumab 40 mg/0.8 mL in a single-dose prefilled pen. The label includes the proprietary name Humira Pen, active ingredient adalimumab, dosage strength, and volume, with usage indicated for subcutaneous injection. Labeler is AbbVie Inc. The carton also shows directions for pharmacists and various product information including warnings.*

FDA Label Image

Ndc 0074-4339-02 2 Single-dose Prefilled Pens Humira® Penadalimumab40 mg/0.8 mLfor Subcutaneous Use Onlyattention Pharmacist: Each Patient Is Required To Receive The Enclosed Medication Guide.needle Cover For Syringe May Contain Dry Natural Rubber.the Entire Carton Is To Be Dispensed As A Unit.return To Pharmacy If Dose Tray Seal Is Broken Or Missing. This Carton Contains:• 2 Dose Trays (each Containing 1 Single-dose Prefilled Pen With 1/2 Inch Length Fixed Needle)• 2 Alcohol Preps• 1 Medication Guide • 1 Package Insert• 1 Instructions For Usewww.humira.comrx Onlyabbvie (Humira 42)

Packaging label for Humira Pen (adalimumab) by AbbVie Inc. The label indicates it is a starter package intended for initial doses. It features a predominantly maroon and white color scheme with some blue and yellow-orange accents. The label includes the product's proprietary name, generic name, and presentation as a pen for subcutaneous injection.*

FDA Label Image

Ndc 0074-4339-06 Starter Package For (Crohn’s Disease,)

Packaging label for Humira Pen, containing adalimumab with a strength of 40 mg per 0.8 mL. The label shows it is a prefilled pen for subcutaneous use. The labeler is AbbVie Inc. The packaging includes dosing information for initial and subsequent doses and branding details.*

FDA Label Image

Ndc 0074-4339-07 Psoriasis/uveitis/adolescenthidradenitis Suppurativa Starter Package4 Single-doseprefilled Pens Humira® Pen Adalimumab40 mg/0.8 mLfor Subcutaneous Use Onlyeach Sterile Single-doseprefilled Pen Contains:adalimumab.................................................40 mg Sodium Chloride.........................................4.93 mg Monobasic Sodium Phosphate Dihydrate.......0.69 mg Dibasic Sodium Phosphate Dihydrate............1.22 mg Sodium Citrate............................................0.24 mg Citric Acid Monohydrate..............................1.04 mg Mannitol......................................................9.6 mg Polysorbate 80.............................................0.8 mg Water For Injection. Sodium Hydroxide Added As Necessary To Adjust Ph. Contains No Preservatives.no U.s. Standard Of Potency.medication Guide For Patient Enclosed.needle Cover For Syringe May Contain Dry Natural Rubber.carton Contains:• 4 Dose Trays (each Containing 1 Single-dose Prefilled Pen With 1/2 Inch Length Fixed Needle)• 4 Alcohol Preps• 1 Package Insert• 1 Medication Guide• Instructions For Usethe Entire Carton Is To Be Dispensed As A Unit. Do Not Accept If Seal Is Broken Or Missing.return To Pharmacy If Dose Tray Seal Is Broken Or Missing.www.humira.com Rx Onlyabbvie (Humira 44)

Box packaging design for Humira Pen adalimumab 40 mg/0.8 mL prefilled pen by AbbVie Inc. The label states it contains 2 single-dose prefilled pens for subcutaneous use only. The packaging highlights that it is Rx only and includes a needle cover warning. The label design uses maroon, blue, and white colors with dosage details and manufacturer information.*

FDA Label Image

Ndc 0074-4339-71 Not For Sale2 Single-dose Prefilled Pens Humira® Pen Adalimumab40 mg/0.8 mLfor Subcutaneous Use Onlyattention Physician: Each Patient Is Required To Receive The Enclosed Medication Guide.needle Cover For Syringe May Contain Dry Natural Rubber.the Entire Carton Is To Be Dispensed As A Unit.return To Physician If Dose Tray Seal Is Broken Or Missing. This Carton Contains:• 2 Dose Trays (each Containing 1 Single-dose Prefilled Pen With 1/2 Inch Length Fixed Needle)• 2 Alcohol Preps• 1 Medication Guide• 1 Package Insert• 1 Instructions For Usewww.humira.com Rx Onlyabbvie (Humira 45)

Packaging label for Humira Pen (adalimumab) by AbbVie Inc. The label shows a multi-panel unfolded carton design with a maroon, yellow, and blue color scheme. The front panel prominently displays the product name Humira Pen with active ingredient adalimumab, indicating use as a starter package. The label includes legal and barcode sections and dosing information panels, consistent with prescription injectable medication packaging.*

FDA Label Image

Ndc 0074-4339-73 Not For Salestarter Package For (Crohn’s Disease,)

Packaging label for Humira 40 mg/0.4 mL with adalimumab, produced by AbbVie Inc. The label is for a two single-dose prefilled syringe package intended for subcutaneous use only. Key features include dosage strength, needle gauge (29 gauge), a caution statement for pharmacists, storage instructions, and the AbbVie and Humira logos.*

FDA Label Image

Ndc 0074-6347-02 2 Single-dose Prefilled Syringeshumira® Adalimumab10 mg/0.2 mLfor Subcutaneous Use Onlyplease See Package Insert For Full Prescribing Information. This Carton Contains:medication Guide For Patient Enclosed. Needle Covers For Syringe May Contain Dry Natural Rubber. Carton Contains 2 Dose Trays, 2 Alcohol Preps, 1 Package Insert, 1 Medication Guide And Instructions For Use. Each Dose Tray Contains 1 Single-dose Prefilled Syringe With 1/2 Inch Length Fixed Needle. The Entire Carton Is To Be Dispensed As A Unit. Return To Pharmacy If Dose Tray Seal Is Broken Or Missing. Www.humira.com Rx Onlyabbvie (Humira 47)

Packaging label for Humira Pen, a single-dose prefilled pen containing adalimumab 40 mg/0.4 mL for subcutaneous use. The label includes dosage strength, volume, needle gauge (29 gauge), manufacturer AbbVie Inc., and handling instructions such as storage and warnings. The design features blue and white background with pink and yellow highlights.*

FDA Label Image

Ndc 0074-0243-02 2 Single-dose Prefilled Syringes40 mg/0.4 mL29 Gauge Needlehumira®adalimumab40 mg/0.4 mLfor Subcutaneous Use Onlyattention Pharmacist: Each Patient Is Required To Receive The Enclosed Medication Guide. Needle Cover For Syringe Is Not Made With Natural Rubber Latex. The Entire Carton Is To Be Dispensed As A Unit.return To Pharmacy If Dose Tray Seal Is Broken Or Missing. This Carton Contains:• 2 Dose Trays (each Containing 1 Single-dose Prefilled Syringe With 29 Gauge 1/2 Inch Length Fixed Needle)• 2 Alcohol Preps• 1 Medication Guide• 1 Package Insert• 1 Instructions For Usehumira.comrx Onlyabbvie (Humira 48)

Packaging label for Humira Pen, containing 2 single-dose prefilled pens of adalimumab 40 mg/0.4 mL for subcutaneous use only. The label displays dosage strength, needle gauge (29G), manufacturer AbbVie Inc., and safety instructions including storage and handling. The carton is blue with prominent red and white text.*

FDA Label Image

Ndc 0074-0554-01 1 Single-dose Prefilled Pen29 Gauge Needlehumira® Pen Adalimumab40 mg/0.4 mLfor Subcutaneous Use Onlyattention Pharmacist: Each Patient Is Requiredto Receive The Enclosed Medication Guide.the Entire Carton Is To Be Dispensed As A Unit.return To Pharmacy If Dose Tray Seal Is Broken Or Missing. This Carton Contains:• 1 Dose Tray (containing 1 Single-dose Prefilled Pen With 29 Gauge 1/2 Inch Length Fixed Needle)• 2 Alcohol Preps• 1 Medication Guide• 1 Package Insert• 1 Instructions For Usehumira.comrx Onlyabbvie (Humira 49)

Carton packaging for Humira Pen by AbbVie Inc., containing adalimumab 40 mg/0.4 mL. The label shows this is a single-dose pen with 4 prefilled syringes. The design uses purple and magenta colors with dosage instructions and branding visible on various panel faces.*

FDA Label Image

Ndc 0074-0554-02 2 Single-dose Prefilled Penshumira® Pen Adalimumab40 mg/0.4 mLfor Subcutaneous Use Only40 mg/0.4 mL29 Gauge Needle Attention Pharmacist: Each Patient Is Requiredto Receive The Enclosed Medication Guide.the Entire Carton Is To Be Dispensed As A Unit.return To Pharmacy If Dose Tray Seal Is Broken Or Missing. This Carton Contains:• 2 Dose Trays (each Containing 1 Single-dose Prefilled Penwith 29 Gauge 1/2 Inch Length Fixed Needle) • 2 Alcohol Preps• 1 Medication Guide• 1 Package Insert• 1 Instructions For Usehumira.comrx Onlyabbvie (Humira 4a)

Packaging label for Humira Pen by AbbVie Inc., featuring the proprietary name Humira and the active ingredient adalimumab. The label shows detailed folding and cutting lines for the pen's outer carton, with multiple panels containing text, barcodes, and color-coded sections. The main color scheme includes a deep maroon background with accents of white, blue, and orange.*

FDA Label Image

Ndc 0074-0554-04 Psoriasis/uveitis/adolescent Hidradenitis Suppurativa Starter Package4 Single-useprefilled Pens Humira® Pen Adalimumab40 mg/0.4 mLfor Subcutaneous Use Onlyeach Sterile Single-useprefilled Pen Contains:adalimumab..................................................40 mg Mannitol.......................................................16.8 mg Polysorbate 80..............................................0.4 mg Water For Injection. Contains No Preservatives.no U.s. Standard Of Potency.medication Guide For Patient Enclosed.carton Contains:• 4 Dose Trays (each Containing1 Single-use Prefilled Pen With29 Gauge 1/2 Inch Length Fixed Needle) • 4 Alcohol Preps• 1 Package Insert• 1 Medication Guide• Instructions For Usethe Entire Carton Is To Be Dispensed As A Unit. Do Not Accept If Seal Is Broken Or Missing.return To Pharmacy If Dose Tray Sealis Broken Or Missing.www.humira.comrx Onlyabbvie (Humira 4b)

Packaging label for Humira Pen 40 mg/0.4 mL, containing a single-dose prefilled pen for subcutaneous use. The label displays the brand name Humira with the active ingredient adalimumab. The package includes instructions and warnings, featuring a 29-gauge 1/2 inch needle. Labeler is AbbVie Inc., with directions for use and storage.*

FDA Label Image

Ndc 0074-0554-06 Starter Package For (Crohn’s Disease,)

Humira 80 mg/0.8 mL prefilled syringe carton label. The packaging includes the proprietary name Humira and strength 80 mg/0.8 mL. The labeler is AbbVie Inc. The layout shows multiple panels of the carton including areas for barcodes and usage information.*

FDA Label Image

Ndc 0074-0554-74 Not For Sale1 Single-dose Prefilled Pen29 Gauge Needlehumira® Pen Adalimumab40 mg/0.4 mLfor Subcutaneous Use Onlyattention Physician: Each Patient Is Requiredto Receive The Enclosed Medication Guide.the Entire Carton Is To Be Dispenses As A Unit.return To Physician If Dose Tray Seal Is Broken Or Missing. This Carton Contains:• 1 Dose Tray (containing 1 Single-dose Prefilled Penwith 29 Gauge 1/2 Inch Length Fixed Needle) • 2 Alcohol Preps• 1 Medication Guide• 1 Package Insert• I Instructions For Usehumira.comrx Onlyabbvie (Humira 4d)

Packaging label for Humira (adalimumab) 80 mg/0.8 mL prefilled syringe by AbbVie Inc. The label indicates it is a starter pack for pediatric Crohn's disease and includes dosing instructions with graphics. The design features brand name, active ingredient, dosage strength, quantity of three prefilled syringes, and administration guidelines for subcutaneous use only.*

FDA Label Image

Ndc 0074-2540-01 1 Single-dose Prefilled Syringehumira® Adalimumab80 mg/0.8 mLfor Subcutaneous Use Only80 mg/0.8 mL29 Gauge Needleattention Pharmacist: Each Patient Is Required To Receive The Enclosed Medication Guide.needle Cover For Syringe Is Not Made With Natural Rubber Latex. The Entire Carton Is To Be Dispensed As A Unit.return To Pharmacy If Dose Tray Seal Is Broken Or Missing. This Carton Contains:• 1 Dose Tray (containing 1 Single-dose Prefilled Syringe With 29 Gauge 1/2 Inch Length Fixed Needle)• 2 Alcohol Preps• 1 Medication Guide• 1 Package Insert• 1 Instructions For Usehumira.com Rx Onlyabbvie (Humira 4e)

Humira pediatric Crohn's disease medication carton packaging label from AbbVie Inc. The label features dosage and administration details, including 80 mg/0.8 mL and 40 mg/0.4 mL doses, visual instructions for use, and various warnings and instructions. The layout includes blue, orange, and purple color elements designed for patient and caregiver guidance.*

FDA Label Image

Ndc 0074-2540-03 Pediatric Crohn’s Diseasestarter Pack For Pediatric Patients ≥40 Kg3 Single-dose Prefilled Syringeshumira®adalimumab80 mg/0.8 mLfor Subcutaneous Use Only80 mg/0.8 mL29 Gauge Needleeach 80 mg/0.8 mL Sterile Single-dose Prefilled Syringe Contains: Adalimumab..................................................80 mg Mannitol.......................................................33.6 mg Polysorbate 80..............................................0.8 mg Water For Injection, Usp Contains No Preservatives No U.s. Standard Of Potency Attention Pharmacist: Each Patient Is Required To Receive The Enclosed Medication Guide.needle Cover For Syringe Is Not Made With Natural Rubber Latex.carton Contains:• 3 Dose Trays (each Containing 1 Single-dose Prefilled Syringe With 29 Gauge 1/2 Inch Length Fixed Needle)• 4 Alcohol Preps• 1 Package Insert• 1 Medication Guide• 1 Instructions For Usethe Entire Carton Is To Be Dispensed As A Unit. Do Not Accept If Seal Is Broken Or Missing.return To Pharmacy If Dose Tray Seal Is Broken Or Missing.humira.comrx Onlyabbvie (Humira 4f)

Packaging label for Humira Pen containing adalimumab. The label indicates a strength of 80 mg per 0.8 mL in a single-dose prefilled pen. The labeler is AbbVie Inc. The package is primarily blue and white with purple and orange accents and includes use and dosage information for subcutaneous injection.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.